Estrogen Replacement to Reduce Risk of Neurologic Injury After Coronary Artery Bypass Graft Surgery
Stopped DSMB stopped the study based on conclusion of likely futility of treatment on the primary outcome.
Conditions
- Coronary Disease
- Cardiovascular Diseases
- Heart Diseases
- Neurologic Manifestations
Interventions
- DRUG: Estrogen Replacement Therapy
- PROCEDURE: Surgery
Sponsor
National Heart, Lung, and Blood Institute (NHLBI)